Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Unknown 5Completed 4Terminated 2Not yet recruiting 2Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 2Thoracic 1

Conditions

Advanced Malignant Solid Tumors 2Thymoma 1Small Cell Lung Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Advanced Cancer 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × vorolanib × Clear all
NCT03583086 2024-10-08

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Vanderbilt-Ingram Cancer Center

Phase 1/2 Completed
88 enrolled 20 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Thymoma, Small Cell Lung Carcinoma

NCT04328506 2021-11-26

Bioequivalency Study of CM082 Tablet in Healthy Volunteers

AnewPharma

Phase 1 Completed
96 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT04126668 2020-05-21

A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

AnewPharma

Phase 1 Completed
24 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT01863485 2019-07-05

Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China

AnewPharma

Phase 1 Completed
44 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡